Français
ItalianoBond AbbVie 5.6% ( US00287YEB11 ) in USD
| Issuer | AbbVie | ||||||||
| Market price |  100.61 % ▲ |
||||||||
| Country |  United States
|
||||||||
| ISIN code |
 US00287YEB11 ( in USD )
|
||||||||
| Interest rate | 5.6% per year ( payment 2 times a year) | ||||||||
| Maturity | 15/03/2055 | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | / | ||||||||
| Total amount | / | ||||||||
| Cusip | 00287YEB1 | ||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||||
| Next Coupon | 15/09/2026 ( In 20 days ) | ||||||||
| Detailed description |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEB11, pays a coupon of 5.6% per year. The coupons are paid 2 times per year and the Bond maturity is 15/03/2055 The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEB11, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by AbbVie ( United States ) , in USD, with the ISIN code US00287YEB11, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||
| |||||||||